Encure Medical Private Limited
About Encure Medical Private Limited
Data last updated:
Encure Medical Private Limited is a foreign private limited company based in Thane, Maharashtra, India, a subsidiary of Clin Rx Reasearch Llc. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 14 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2015FTC261892.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prakashchandra Shikharchand Jain and Vandana Jain Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹35,452, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹6,152 (net margin 17.4%) and EBITDA of ₹6,152 (EBITDA margin 17.4%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Encure Medical Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNamokar Bhavan Bunglow Plot No.56 Rsc 12 Yashodhan Nagar Opp Sneh Bhadhan Societ, Y, Thane, Maharashtra, India – 400606
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Encure Medical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Encure Medical Private Limited
FY 2025 filings availableEncure Medical Private Limited reported revenue of ₹35,452 (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 22% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6,152 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6,152 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.4% | ||||
| Net Profit Margin | 17.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Encure Medical Private Limited, buy the company report.
Board of directors of Encure Medical Private Limited
Encure Medical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prakashchandra Shikharchand Jain | Director | 14 Feb 2015 | 11 Years 8 Months | Current |
| Vandana Jain Agarwal | Director | 14 Feb 2015 | 11 Years 8 Months | Current |
Peer comparison
Encure Medical Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Envigo Research Private Limited | ₹47,000 (FY 2022) | 571.0% | Ahmedabad, Gujarat, India | |||
| Oshni Medicines Research and Development Organization Private Limited | ₹43,500 (FY 2025) | -89.0% | Namakkal, Tamil Nadu, India | |||
| Novita Healthntech Private Limited | ₹40,389 (FY 2023) | 8.0% | Hyderabad, Telangana, India | |||
| Institute of Pharmaceutical & Healthcare Management and Rese | ₹39,624 (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| SHL Research Private Limited | ₹38,000 (FY 2025) | 12.0% | Chennai, Tamil Nadu, India | |||
| Encure Medical Private Limitedthis company | ₹35,452 (FY 2025) | ₹6,152 | 17.4% | 22.0% | Thane, Maharashtra, India | |
| Cyto-Sure Private Limited | ₹35,400 (FY 2022) | Bangalore, Karnataka, India | ||||
| Reliance Research and Development Services Private Limited | ₹33,502 (FY 2025) | 0.0% | Mumbai, Maharashtra, India | |||
| Dhathri Ayurveda Hospitals and Researches Private Limited | ₹33,300 (FY 2025) | Ernakulam, Kerala, India | ||||
| Avyatha Medical Research Projects Private Limited | ₹32,133 (FY 2025) | -96.0% | Dhampur, Uttar Pradesh, India | |||
| International Medical Research & Scientific Center Private Limited | ₹25,000 (FY 2024) | -92.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of Encure Medical Private Limited, buy the company report.
Auditor
Encure Medical Private Limited is audited by M R P & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M R P & Associates | FY 2023 | 143664 |
Shareholding
The shareholding of Encure Medical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Encure Medical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Encure Medical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Encure Medical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Encure Medical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Encure Medical Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Suresh Mangeram Agarwal ceased to be Director on 21 Apr 2019.
Frequently asked questions
Encure Medical is an active foreign private limited company based in Thane, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 14 February 2015 (11+ years old) and is registered under CIN U74120MH2015FTC261892.
Encure Medical has 2 current directors:
- Prakashchandra Shikharchand Jain - Director
- Vandana Jain Agarwal - Director
The latest financial statements of Encure Medical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Encure Medical is U74120MH2015FTC261892. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Encure Medical was incorporated on 14 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Encure Medical by revenue are Envigo Research Private Limited, Oshni Medicines Research and Development Organization Private Limited, Novita Healthntech Private Limited, Institute of Pharmaceutical & Healthcare Management and Rese, SHL Research Private Limited and 5 more, all in the Pharma industry (Contract Research).
Suresh Mangeram Agarwal ceased to be Director on 21 Apr 2019. Prakashchandra Shikharchand Jain was appointed as Director on 14 Feb 2015. Vandana Jain Agarwal was appointed as Director on 14 Feb 2015.
The registered office of Encure Medical is at Namokar Bhavan Bunglow Plot No.56 Rsc 12 Yashodhan Nagar Opp Sneh Bhadhan Societ, Y, Thane, Maharashtra, India – 400606.
Encure Medical operates in the pharma industry, in the pharma contract r and d segment.
The compliance status of Encure Medical is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.
Encure Medical can be reached at its registered office: Namokar Bhavan Bunglow Plot No.56 Rsc 12 Yashodhan Nagar Opp Sneh Bhadhan Societ, Y, Thane, Maharashtra, India – 400606.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
